Overnight Healthcare: Senators blast Shkreli's pricing scheme; US Zika cases rising

TURING ON THE HOT SEAT: It was the Senate's turn to tear into Martin Shkreli's former company, Turing Pharmaceuticals, on Thursday.

The Senate Aging Committee, led by Sens. Susan CollinsSusan CollinsPolitical bedfellows of 2016 may be strange but not unheard of Obama creates new national monument in Maine GOP senator considering Libertarian ticket MORE (R-Maine) and Claire McCaskillClaire McCaskillSenate Dem: You can say Trump and his 'friend' Putin founded ISIS Sunday shows preview: Trump's tough week McCaskill blasts Gingrich for comparing Trump to Truman MORE (D-Mo.), spent more than two hours railing against top executives at Turing over high drug prices.

Among the most vocal was Sen. Elizabeth WarrenElizabeth WarrenAmazon hires antitrust lobbyist Jill Stein helps Trump as Ralph Nader helped Bush Scott Brown calls ex-Fox host harassment charge ‘totally false’ MORE (D-Mass.), who repeatedly questioned the interim CEO Ronald Tilles on whether he believed the $750-per-pill price of Daraprim was "ethical."

"Almost no patient pays that price," Tilles said during a heated back-and-forth with Warren.

"Saying 'almost' is not very good if it's your child who's in trouble," Warren retorted. "You can't just shove this off."

Shkreli, the company's former lightning rod CEO, has since stepped down after facing federal fraud charges separate from his work at the company. Much of his former coworkers' appearance at the Senate on Thursday was doing damage control. Read more here. http://bit.ly/1Z6gLGZ

ZIKA CASES AT 450 AND RISING: About 450 people in the United States have been infected with the Zika virus, the White House's top health official told The Hill on Thursday.

The figure, which includes Puerto Rico and the continental U.S., shows an increase of about 90 cases from the department's latest Zika report about one week ago. Read more here. http://bit.ly/1PexPmI

$200K WORTH OF TRUMP ATTACKS ON OBAMACARE: The influential Club for Growth released a 30-second ad on Thursday, warning that Trump has "repeatedly reaffirmed his support for a health care mandate and for government-run health care."

The ad, worth about $200,000, will be shown statewide in Utah ahead of its majority-take-all caucus. Read more here: http://bit.ly/1U9IbNb

CANCER GROUPS LINE UP AGAINST MEDICARE COST PLAN: Dozens of cancer groups are pushing back against the Obama administration's plans for reforming payments under Medicare Part B, which it warns "would wreak havoc" on patients.

The administration announced last week that it plans to pilot a new Part B payment structure intended to incentivize doctors to prescribe "higher-value" drugs rather than simply the most expensive drugs available. That pilot would begin sometime this fall, pending the new federal regulations. Read more here: http://bit.ly/22ot0UT

HATCH STILL SEES "PROBLEMS" WITH HHS NOMINEE: Senate Finance Committee Chairman Orrin HatchOrrin HatchGOP lawmakers call for overhaul of proposed corporate tax rules DEA decision against reclassifying marijuana ignores public opinion Trump op-ed counters Clinton’s pitch to Utah voters MORE (R-Utah) says there is a "real question" about President Obama's nominee to be deputy Health and Human Services secretary, in part over questions about an abortion law investigation moving too slowly. Mary Wakefield's nomination is currently before Hatch's committee.

"There's a real question right now about her and I intend to try and call her up, but we'll have to work through the problems," Hatch told The Hill. Read more here. http://bit.ly/1TRUxcr

COOL MAP ALERT: Check out this new map from CMS, with more county-level Medicare data than you ever thought you wanted. Which states are paying the most for obesity? (Nevada, West Virginia, Colorado). Which states have the highest prevalence of Alzheimer's disease? (New York, Connecticut, New Jersey, Texas, Florida). Which states have the most depression cases? (Maine, Minnesota, Ohio, Oklahoma). Plus there's three years of data.


Docs who get company cash tend to prescribe more brand-name meds (ProPublica)

Lead-tainted water in schools, day cares across US (USA Today)

UnitedHealth takes on CVS-Express Scripts with Walgreens deal (Bloomberg)  

CEO of GlaxoSmithKline to retire (Wall Street Journal)


Alabama punts Medicaid to special session (AL.com)

Arkansas governor hosting town hall on controversial Medicaid plan (Fox 13)

Editorial: Prescription limits aren't the solution to Maine's heroin crisis (Bangor Daily News)

Bill empowering pharmacists on birth control advances in Tennessee House (Tennessean)


Michigan governor, EPA chief under fire for Flint http://bit.ly/1pOHfRq

WHO: West Africa free from Ebola, for now http://bit.ly/1nRWmIe

Send tips and comments to Sarah Ferris, sferris@thehill.com, and Peter Sullivan, psullivan@thehill.com. Follow us on Twitter: @thehill@sarahnferris@PeterSullivan4